Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Pain in Rheumatoid or Psoriatic Arthritis
NCT04269993Phase 2Terminated
- Sponsor
- Brown University
- Start
- May 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabis in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) (2 arms), sponsored by Brown University. Primary endpoint: Subjective Pain Level Post-vaporization. Started May 2022; status: terminated.
02
Drugs
cannabis
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT04269993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269993.